Lyn Baranowski's most recent trade in Avalyn Pharma Inc. was a trade of 501,033 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 29, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avalyn Pharma Inc | Lyn Baranowski | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2026 | 501,033 | 501,033 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Lyn Baranowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 22,240 | 22,240 | - | - | Stock Option (Right to Buy) |